Assessment of the safety of recombinant tissue factor pathway inhibitor in patients with severe sepsis: a multicenter, randomized, placebo-controlled, single-blind, dose escalation study. (Q53320452)
scientific article published in November 2001
Language:
(P31) (Q13442814)
(P304) 2081-2089
(P407) (Q1860)
(P433) 11
(P478) 29
(P577) Thursday, November 1, 2001
(P921) (Q181600)
(Q269829)
(Q183134)
(P1433) (Q5186605)
(P1476) "Assessment of the safety of recombinant tissue factor pathway inhibitor in patients with severe sepsis: a multicenter, randomized, placebo-controlled, single-blind, dose escalation study." (language: en)
(P2093) Abraham E
Reinhart K
Svoboda P
Seibert A
Olthoff D
Dal Nogare A
Postier R
Hempelmann G
Butler T
Martin E
Zwingelstein C
Percell S
Shu V
Leighton A
Creasey AA
other details
description scientific article published in November 2001

External Links